If anyone is curious, a Powered Air Purifying Respirator (PAPR) is equipment used to filter an air supply through a hose into an enclosed helmet – it’s what healthcare workers would ideally be wearing when intubating an infected/contagious patient. These should not be confused with ventilators, which are completely different (and much more expensive) devices used for patient life support. The company in question has no role in making the latter
PAPRs are helpful (can always use more), but their use is episodic during aerosol generating medical procedures – it’s not something a clinician would wear all the time, which is why you won’t have heard of a big shortage. They’re also not hugely expensive. Even if this contract was for 100,000 of them, the price tag should not be more than about 250 million (in fact it should be less, since they’re buying in bulk). Something does not add up. Either they have purchased far more than just PAPRs, or they have purchased them at rip-off pricing, or both
Edited to add: oops I misread the story. The no-bid contract for 100,000 PAPRs was for 96 million. That’s $960 per PAPR. I hate to say it, but that’s not bad. Doesn’t mean there was any need at all for a no-bid contract, because many companies make these things. But that is a good price. The ProPublica story should have included that context